Global Nucleic Acid Delivery System Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Nucleic Acid Delivery System Market Research Report 2024
Nucleic Acid Delivery System (NADS) refers to a range of technologies and methods that are used to deliver nucleic acids, such as DNA or RNA, into cells or tissues. In gene therapy and genetic engineering, NADS play a critical role in delivering therapeutic genes to target cells to treat genetic diseases, as well as in introducing new genetic traits into organisms for various purposes.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
According to MRAResearch’s new survey, global Nucleic Acid Delivery System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Delivery System market research.
Key companies engaged in the Nucleic Acid Delivery System industry include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nucleic Acid Delivery System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Delivery System market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nucleic Acid Delivery System report covers below items
Chapter 1Product Basic Information (Definition, Vector and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Vector Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
According to MRAResearch’s new survey, global Nucleic Acid Delivery System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Delivery System market research.
Key companies engaged in the Nucleic Acid Delivery System industry include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nucleic Acid Delivery System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Delivery System market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Segment by Application
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nucleic Acid Delivery System report covers below items
Chapter 1Product Basic Information (Definition, Vector and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Vector Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices